WP 1.2 Clinical intervention trial: randomized controlled trial (RCT) substitution with PUFA

Objective: To study the clinical efficacy of PUFA (docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA)) administration for 6 months in hospitalized adolescents with AN in comparison to a placebo and to healthy controls at 6 months and 1 year follow-up.

Team:

Prof. Dr. med. Beate. Herpertz-Dahlmann
(Consortium Coordinator, PI), Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
bherpertzukaachende

PD Dr. med. Jochen. Seitz
(Co-coordinator, PI), Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
jseitzukaachende

Lara Keller, M. Sc
(Local coordinator), Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
lkellerukaachende

Dr. med. Brigitte Dahmen, M. Sc
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
bdahmenukaachende

Samira Schreiber
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
sschreiberukaachende

Melissa Medoch
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
mmedochukaachende

Lilly Kneisel, cand med.
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
lkneiselukaachende

Hanna Simmler
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
hsimmlerukaachende

Lia Rahnamay
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
lrahnamayukaachende

Miranda van Egmond, cand med.
Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
mivanegmondukaachende